Temporal Trend of Cardiovascular Disease Burden Among Cancer Patients Between 2005 and 2022: Nationwide Population-Based Cohort Study in South Korea
Open Access
- 1 January 2026
- journal article
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (5) , 404-418
Abstract
Cho I, et al. Korean Circ J. 2026 ;56:e53. https://doi.org/10.4070/kcj.2025.0171Keywords
Funding Information
- Working Group on Cardio-Oncology of the Korean Society of Cardiology (2023-02-04)
- National Research Foundation of Korea (RS-2024-00341426)
This publication has 29 references indexed in Scilit:
- Risk of Cardiovascular Disease in Cancer Survivors after Systemic TreatmentJACC: Cardiooncology, 2025
- The FDA and the Cardiovascular CommunityJACC, 2024
- Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010–2022American Journal of Preventive Medicine, 2023
- Risk of Cancer After Diagnosis of Cardiovascular DiseaseJACC: Cardiooncology, 2023
- Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management StrategiesJACC: Cardiooncology, 2023
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)European Heart Journal - Cardiovascular Imaging, 2022
- Cardiovascular disease burden in adult patients with cancer: An 11-year nationwide population-based cohort studyInternational Journal of Cardiology, 2020
- Common risk factors for heart failure and cancerCardiovascular Research, 2019
- Activity and Outcomes of a Cardio-Oncology Service in the United Kingdom—A Five-Year ExperienceEuropean Journal of Heart Failure, 2018
- Cardiotoxicity of anticancer treatmentsNature Reviews Cardiology, 2015